{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T14:32:11Z","timestamp":1793716331684,"version":"4.6.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2019,11,9]],"date-time":"2019-11-09T00:00:00Z","timestamp":1573257600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,9]],"date-time":"2019-11-09T00:00:00Z","timestamp":1573257600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100011913","name":"Kaohsiung Veterans General Hospital","doi-asserted-by":"publisher","award":["VGHKS107-174, VGHKS108-178"],"award-info":[{"award-number":["VGHKS107-174, VGHKS108-178"]}],"id":[{"id":"10.13039\/501100011913","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Ministry of Science and Technology","award":["MOST 106-2320-B-075B-002-MY2 and MOST 108-2320-B-075B-003"],"award-info":[{"award-number":["MOST 106-2320-B-075B-002-MY2 and MOST 108-2320-B-075B-003"]}]},{"DOI":"10.13039\/501100007354","name":"Yen Tjing Ling Medical Foundation","doi-asserted-by":"publisher","award":["CI-107-13"],"award-info":[{"award-number":["CI-107-13"]}],"id":[{"id":"10.13039\/501100007354","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Oral Invest"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1007\/s00784-019-03129-y","type":"journal-article","created":{"date-parts":[[2019,11,9]],"date-time":"2019-11-09T06:03:20Z","timestamp":1573279400000},"page":"2673-2682","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Guanylate-binding protein 6 is a novel biomarker for tumorigenesis and prognosis in tongue squamous cell carcinoma"],"prefix":"10.1007","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7849-8940","authenticated-orcid":false,"given":"Pei-Feng","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung-Chih","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Wen","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huei-Cin","family":"Sie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Hsin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huei-Han","family":"Liou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiin-Tsuey","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuo-Wang","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luo-Ping","family":"Ger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,9]]},"reference":[{"key":"3129_CR1","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/s00784-018-2497-8","volume":"23","author":"R Seta","year":"2019","unstructured":"Seta R, Mascitti M, Campagna R, Sartini D, Fumarola S, Santarelli A, Giuliani M, Cecati M, Muzio LL, Emanuelli M (2019) Overexpression of nicotinamide N-methyltransferase in HSC-2 OSCC cell line: effect on apoptosis and cell proliferation. Clin Oral Investig 23:829\u2013838","journal-title":"Clin Oral Investig"},{"key":"3129_CR2","doi-asserted-by":"publisher","first-page":"16623","DOI":"10.18632\/oncotarget.3932","volume":"6","author":"S Maji","year":"2015","unstructured":"Maji S, Samal SK, Pattanaik L, Panda S, Quinn BA, Das SK, Sarkar D, Pellecchia M, Fisher PB, Dash R (2015) Mcl-1 is an important therapeutic target for oral squamous cell carcinomas. Oncotarget 6:16623\u201316637","journal-title":"Oncotarget"},{"key":"3129_CR3","doi-asserted-by":"publisher","first-page":"671","DOI":"10.4103\/1947-2714.123239","volume":"5","author":"KB Jadhav","year":"2013","unstructured":"Jadhav KB, Gupta N (2013) Clinicopathological prognostic implicators of oral squamous cell carcinoma: need to understand and revise. N Am J Med Sci 5:671\u2013679","journal-title":"N Am J Med Sci"},{"key":"3129_CR4","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1097\/CCO.0b013e32832a68ca","volume":"21","author":"MP Curado","year":"2009","unstructured":"Curado MP, Hashibe M (2009) Recent changes in the epidemiology of head and neck cancer. Curr Opin Oncol 21:194\u2013200","journal-title":"Curr Opin Oncol"},{"key":"3129_CR5","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1089\/jir.2010.0102","volume":"31","author":"DJ Vestal","year":"2011","unstructured":"Vestal DJ, Jeyaratnam JA (2011) The guanylate-binding proteins: emerging insights into the biochemical properties and functions of this family of large interferon-induced guanosine triphosphatase. J Interferon Cytokine Res 31:89\u201397","journal-title":"J Interferon Cytokine Res"},{"key":"3129_CR6","doi-asserted-by":"publisher","first-page":"e1007876","DOI":"10.1371\/journal.ppat.1007876","volume":"15","author":"C Ji","year":"2019","unstructured":"Ji C, Du S, Li P, Zhu Q, Yang X, Long C, Yu J, Shao F, Xiao J (2019) Structural mechanism for guanylate-binding proteins (GBPs) targeting by the Shigella E3 ligase IpaH9.8. PLoS Pathog 15:e1007876","journal-title":"PLoS Pathog"},{"key":"3129_CR7","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.ijmm.2017.10.013","volume":"308","author":"GJK Praefcke","year":"2018","unstructured":"Praefcke GJK (2018) Regulation of innate immune functions by guanylate-binding proteins. Int J Med Microbiol 308:237\u2013245","journal-title":"Int J Med Microbiol"},{"key":"3129_CR8","doi-asserted-by":"publisher","first-page":"6434","DOI":"10.3748\/wjg.v22.i28.6434","volume":"22","author":"N Britzen-Laurent","year":"2016","unstructured":"Britzen-Laurent N, Herrmann C, Naschberger E, Croner RS, Sturzl M (2016) Pathophysiological role of guanylate-binding proteins in gastrointestinal diseases. World J Gastroenterol 22:6434\u20136443","journal-title":"World J Gastroenterol"},{"key":"3129_CR9","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/j.1600-0714.1981.tb01251.x","volume":"10","author":"E Budtz-Jorgensen","year":"1981","unstructured":"Budtz-Jorgensen E (1981) Oral mucosal lesions associated with the wearing of removable dentures. J Oral Pathol 10:65\u201380","journal-title":"J Oral Pathol"},{"key":"3129_CR10","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1093\/nar\/21.6.1498","volume":"21","author":"S Vincent","year":"1993","unstructured":"Vincent S, Marty L, Fort P (1993) S26 ribosomal protein RNA: an invariant control for gene regulation experiments in eucaryotic cells and tissues. Nucleic Acids Res 21:1498","journal-title":"Nucleic Acids Res"},{"key":"3129_CR11","doi-asserted-by":"crossref","unstructured":"Fu TY, Hsieh IC, Cheng JT, Tsai MH, Hou YY, Lee JH, Liou HH, Huang SF, Chen HC, Yen LM, Tseng HH, Ger LP (2015) Association of OCT4, SOX2, and NANOG expression with oral squamous cell carcinoma progression. J Oral Pathol Med","DOI":"10.1111\/jop.12335"},{"key":"3129_CR12","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1111\/jop.12861","volume":"48","author":"HC Chen","year":"2019","unstructured":"Chen HC, Tseng YK, Shu CW, Weng TJ, Liou HH, Yen LM, Hsieh IC, Wang CC, Wu PC, Shiue YL, Fu TY, Tsai KW, Ger LP, Liu PF (2019) Differential clinical significance of COL5A1 and COL5A2 in tongue squamous cell carcinoma. J Oral Pathol Med 48:468\u2013476","journal-title":"J Oral Pathol Med"},{"key":"3129_CR13","doi-asserted-by":"crossref","unstructured":"Piro AS, Hernandez D, Luoma S, Feeley EM, Finethy R, Yirga A, Frickel EM, Lesser CF, Coers J (2017) Detection of cytosolic Shigella flexneri via a C-terminal triple-arginine motif of GBP1 inhibits actin-based motility. MBio 8","DOI":"10.1128\/mBio.01979-17"},{"key":"3129_CR14","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1016\/j.celrep.2019.04.063","volume":"27","author":"E Braun","year":"2019","unstructured":"Braun E, Hotter D, Koepke L, Zech F, Gross R, Sparrer KMJ, Muller JA, Pfaller CK, Heusinger E, Wombacher R, Sutter K, Dittmer U, Winkler M, Simmons G, Jakobsen MR, Conzelmann KK, Pohlmann S, Munch J, Fackler OT, Kirchhoff F, Sauter D (2019) Guanylate-binding proteins 2 and 5 exert broad antiviral activity by inhibiting furin-mediated processing of viral envelope proteins. Cell Rep 27:2092\u20132104 e10","journal-title":"Cell Rep"},{"key":"3129_CR15","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1093\/carcin\/bgs310","volume":"34","author":"N Britzen-Laurent","year":"2013","unstructured":"Britzen-Laurent N, Lipnik K, Ocker M, Naschberger E, Schellerer VS, Croner RS, Vieth M, Waldner M, Steinberg P, Hohenadl C, Sturzl M (2013) GBP-1 acts as a tumor suppressor in colorectal cancer cells. Carcinogenesis 34:153\u2013162","journal-title":"Carcinogenesis"},{"key":"3129_CR16","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/modpathol.2016.54","volume":"29","author":"K Friedman","year":"2016","unstructured":"Friedman K, Brodsky AS, Lu S, Wood S, Gill AJ, Lombardo K, Yang D, Resnick MB (2016) Medullary carcinoma of the colon: a distinct morphology reveals a distinctive immunoregulatory microenvironment. Mod Pathol 29:528\u2013541","journal-title":"Mod Pathol"},{"key":"3129_CR17","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s12282-012-0404-8","volume":"21","author":"P Godoy","year":"2014","unstructured":"Godoy P, Cadenas C, Hellwig B, Marchan R, Stewart J, Reif R, Lohr M, Gehrmann M, Rahnenfuhrer J, Schmidt M, Hengstler JG (2014) Interferon-inducible guanylate binding protein (GBP2) is associated with better prognosis in breast cancer and indicates an efficient T cell response. Breast Cancer 21:491\u2013499","journal-title":"Breast Cancer"},{"key":"3129_CR18","doi-asserted-by":"publisher","first-page":"177","DOI":"10.2119\/molmed.2009.00172","volume":"16","author":"K Lipnik","year":"2010","unstructured":"Lipnik K, Naschberger E, Gonin-Laurent N, Kodajova P, Petznek H, Rungaldier S, Astigiano S, Ferrini S, Sturzl M, Hohenadl C (2010) Interferon gamma-induced human guanylate binding protein 1 inhibits mammary tumor growth in mice. Mol Med 16:177\u2013187","journal-title":"Mol Med"},{"key":"3129_CR19","doi-asserted-by":"publisher","first-page":"3778","DOI":"10.1021\/pr2004133","volume":"10","author":"CJ Yu","year":"2011","unstructured":"Yu CJ, Chang KP, Chang YJ, Hsu CW, Liang Y, Yu JS, Chi LM, Chang YS, Wu CC (2011) Identification of guanylate-binding protein 1 as a potential oral cancer marker involved in cell invasion using omics-based analysis. J Proteome Res 10:3778\u20133788","journal-title":"J Proteome Res"},{"key":"3129_CR20","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1002\/ijc.23944","volume":"124","author":"DP Guimaraes","year":"2009","unstructured":"Guimaraes DP, Oliveira IM, de Moraes E, Paiva GR, Souza DM, Barnas C, Olmedo DB, Pinto CE, Faria PA, De Moura Gallo CV, Small IA, Ferreira CG, Hainaut P (2009) Interferon-inducible guanylate binding protein (GBP)-2: a novel p53-regulated tumor marker in esophageal squamous cell carcinomas. Int J Cancer 124:272\u2013279","journal-title":"Int J Cancer"},{"key":"3129_CR21","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1111\/j.0022-202X.2004.22613.x","volume":"122","author":"F Fellenberg","year":"2004","unstructured":"Fellenberg F, Hartmann TB, Dummer R, Usener D, Schadendorf D, Eichmuller S (2004) GBP-5 splicing variants: new guanylate-binding proteins with tumor-associated expression and antigenicity. J Invest Dermatol 122:1510\u20131517","journal-title":"J Invest Dermatol"},{"key":"3129_CR22","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1093\/carcin\/bgp052","volume":"30","author":"L Persano","year":"2009","unstructured":"Persano L, Moserle L, Esposito G, Bronte V, Barbieri V, Iafrate M, Gardiman MP, Larghero P, Pfeffer U, Naschberger E, Sturzl M, Indraccolo S, Amadori A (2009) Interferon-alpha counteracts the angiogenic switch and reduces tumor cell proliferation in a spontaneous model of prostatic cancer. Carcinogenesis 30:851\u2013860","journal-title":"Carcinogenesis"},{"key":"3129_CR23","doi-asserted-by":"publisher","first-page":"5568","DOI":"10.1093\/emboj\/20.20.5568","volume":"20","author":"E Guenzi","year":"2001","unstructured":"Guenzi E, Topolt K, Cornali E, Lubeseder-Martellato C, Jorg A, Matzen K, Zietz C, Kremmer E, Nappi F, Schwemmle M, Hohenadl C, Barillari G, Tschachler E, Monini P, Ensoli B, Sturzl M (2001) The helical domain of GBP-1 mediates the inhibition of endothelial cell proliferation by inflammatory cytokines. EMBO J 20:5568\u20135577","journal-title":"EMBO J"},{"key":"3129_CR24","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s40364-018-0136-9","volume":"6","author":"K Walker","year":"2018","unstructured":"Walker K, Boyd NH, Anderson JC, Willey CD, Hjelmeland AB (2018) Kinomic profiling of glioblastoma cells reveals PLCG1 as a target in restricted glucose. Biomark Res 6:22","journal-title":"Biomark Res"},{"key":"3129_CR25","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s00401-018-1806-2","volume":"135","author":"DAM Mustafa","year":"2018","unstructured":"Mustafa DAM, Pedrosa R, Smid M, van der Weiden M, de Weerd V, Nigg AL, Berrevoets C, Zeneyedpour L, Priego N, Valiente M, Luider TM, Debets R, Martens JWM, Foekens JA, Sieuwerts AM, Kros JM (2018) T lymphocytes facilitate brain metastasis of breast cancer by inducing guanylate-binding protein 1 expression. Acta Neuropathol 135:581\u2013599","journal-title":"Acta Neuropathol"},{"key":"3129_CR26","first-page":"369","volume":"20","author":"L Li","year":"2015","unstructured":"Li L, Ma G, Jing C, Liu Z (2015) Guanylate-binding protein 1 (GBP1) promotes lymph node metastasis in human esophageal squamous cell carcinoma. Discov Med 20:369\u2013378","journal-title":"Discov Med"},{"key":"3129_CR27","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1111\/cas.12489","volume":"105","author":"M Fukumoto","year":"2014","unstructured":"Fukumoto M, Amanuma T, Kuwahara Y, Shimura T, Suzuki M, Mori S, Kumamoto H, Saito Y, Ohkubo Y, Duan Z, Sano K, Oguchi T, Kainuma K, Usami S, Kinoshita K, Lee I, Fukumoto M (2014) Guanine nucleotide-binding protein 1 is one of the key molecules contributing to cancer cell radioresistance. Cancer Sci 105:1351\u20131359","journal-title":"Cancer Sci"},{"key":"3129_CR28","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1002\/jcp.22813","volume":"227","author":"M De Donato","year":"2012","unstructured":"De Donato M, Mariani M, Petrella L, Martinelli E, Zannoni GF, Vellone V, Ferrandina G, Shahabi S, Scambia G, Ferlini C (2012) Class III beta-tubulin and the cytoskeletal gateway for drug resistance in ovarian cancer. J Cell Physiol 227:1034\u20131041","journal-title":"J Cell Physiol"},{"key":"3129_CR29","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1186\/s12885-017-3726-2","volume":"17","author":"M Quintero","year":"2017","unstructured":"Quintero M, Adamoski D, Reis LMD, Ascencao CFR, Oliveira KRS, Goncalves KA, Dias MM, Carazzolle MF, Dias SMG (2017) Guanylate-binding protein-1 is a potential new therapeutic target for triple-negative breast cancer. BMC Cancer 17:727","journal-title":"BMC Cancer"},{"key":"3129_CR30","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.1084\/jem.20111102","volume":"208","author":"M Li","year":"2011","unstructured":"Li M, Mukasa A, Inda MM, Zhang J, Chin L, Cavenee W, Furnari F (2011) Guanylate binding protein 1 is a novel effector of EGFR-driven invasion in glioblastoma. J Exp Med 208:2657\u20132673","journal-title":"J Exp Med"},{"key":"3129_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.559","volume":"8","author":"J Zhang","year":"2017","unstructured":"Zhang J, Zhang Y, Wu W, Wang F, Liu X, Shui G, Nie C (2017) Guanylate-binding protein 2 regulates Drp1-mediated mitochondrial fission to suppress breast cancer cell invasion. Cell Death Dis 8:e3151","journal-title":"Cell Death Dis"},{"key":"3129_CR32","first-page":"7914","volume":"15","author":"Q Wang","year":"2018","unstructured":"Wang Q, Wang X, Liang Q, Wang S, Xiwen L, Pan F, Chen H, Li D (2018) Distinct prognostic value of mRNA expression of guanylate-binding protein genes in skin cutaneous melanoma. Oncol Lett 15:7914\u20137922","journal-title":"Oncol Lett"},{"key":"3129_CR33","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1002\/ijc.23764","volume":"123","author":"E Naschberger","year":"2008","unstructured":"Naschberger E, Croner RS, Merkel S, Dimmler A, Tripal P, Amann KU, Kremmer E, Brueckl WM, Papadopoulos T, Hohenadl C, Hohenberger W, Sturzl M (2008) Angiostatic immune reaction in colorectal carcinoma: impact on survival and perspectives for antiangiogenic therapy. Int J Cancer 123:2120\u20132129","journal-title":"Int J Cancer"},{"key":"3129_CR34","doi-asserted-by":"publisher","first-page":"499","DOI":"10.4103\/0973-1482.131403","volume":"10","author":"R Anand","year":"2014","unstructured":"Anand R, Dhingra C, Prasad S, Menon I (2014) Betel nut chewing and its deleterious effects on oral cavity. J Cancer Res Ther 10:499\u2013505","journal-title":"J Cancer Res Ther"},{"key":"3129_CR35","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1186\/s12885-019-5859-y","volume":"19","author":"K Wu","year":"2019","unstructured":"Wu K, Wei J, Liu Z, Yu B, Yang X, Zhang C, Abdelrehem A, Zhang C, Li S (2019) Can pattern and depth of invasion predict lymph node relapse and prognosis in tongue squamous cell carcinoma. BMC Cancer 19:714","journal-title":"BMC Cancer"},{"key":"3129_CR36","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1001\/jamaoto.2016.3455","volume":"142","author":"AY Han","year":"2016","unstructured":"Han AY, Kuan EC, Mallen-St Clair J, Alonso JE, Arshi A, St John MA (2016) Epidemiology of squamous cell carcinoma of the lip in the United States: a population-based cohort analysis. JAMA Otolaryngol Head Neck Surg 142:1216\u20131223","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"3129_CR37","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.dci.2019.02.014","volume":"96","author":"T Gu","year":"2019","unstructured":"Gu T, Yu D, Fan Y, Wu Y, Yao YL, Xu L, Yao YG (2019) Molecular identification and antiviral function of the guanylate-binding protein (GBP) genes in the Chinese tree shrew (Tupaia belangeri chinesis). Dev Comp Immunol 96:27\u201336","journal-title":"Dev Comp Immunol"},{"key":"3129_CR38","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/mi.2012.41","volume":"5","author":"CT Capaldo","year":"2012","unstructured":"Capaldo CT, Beeman N, Hilgarth RS, Nava P, Louis NA, Naschberger E, Sturzl M, Parkos CA, Nusrat A (2012) IFN-gamma and TNF-alpha-induced GBP-1 inhibits epithelial cell proliferation through suppression of beta-catenin\/TCF signaling. Mucosal Immunol 5:681\u2013690","journal-title":"Mucosal Immunol"},{"key":"3129_CR39","doi-asserted-by":"publisher","first-page":"2955","DOI":"10.1042\/BCJ20180123","volume":"475","author":"B Unterer","year":"2018","unstructured":"Unterer B, Wiesmann V, Gunasekaran M, Sticht H, Tenkerian C, Behrens J, Leone M, Engel FB, Britzen-Laurent N, Naschberger E, Wittenberg T, Sturzl M (2018) IFN-gamma-response mediator GBP-1 represses human cell proliferation by inhibiting the Hippo signaling transcription factor TEAD. Biochem J 475:2955\u20132967","journal-title":"Biochem J"},{"key":"3129_CR40","unstructured":"Alspach E, Lussier DM, Schreiber RD (2019) Interferon gamma and its important roles in promoting and inhibiting spontaneous and therapeutic cancer immunity. Cold Spring Harb Perspect Biol 11"},{"key":"3129_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003933","volume":"10","author":"SE Whitmore","year":"2014","unstructured":"Whitmore SE, Lamont RJ (2014) Oral bacteria and cancer. PLoS Pathog 10:e1003933","journal-title":"PLoS Pathog"},{"key":"3129_CR42","doi-asserted-by":"crossref","unstructured":"Liu PF, Chang HW, Cheng JS, Lee HP, Yen CY, Tsai WL, Cheng JT, Li YJ, Huang WC, Lee CH, Ger LP, Shu CW (2018) Map1lc3b and Sqstm1 modulated autophagy for tumorigenesis and prognosis in certain subsites of oral squamous cell carcinoma. J Clin Med 7","DOI":"10.3390\/jcm7120478"},{"key":"3129_CR43","doi-asserted-by":"publisher","first-page":"e0178581","DOI":"10.1371\/journal.pone.0178581","volume":"12","author":"PF Liu","year":"2017","unstructured":"Liu PF, Kang BH, Wu YM, Sun JH, Yen LM, Fu TY, Lin YC, Liou HH, Lin YS, Sie HC, Hsieh IC, Tseng YK, Shu CW, Hsieh YD, Ger LP (2017) Vimentin is a potential prognostic factor for tongue squamous cell carcinoma among five epithelial-mesenchymal transition-related proteins. PLoS One 12:e0178581","journal-title":"PLoS One"},{"key":"3129_CR44","doi-asserted-by":"publisher","first-page":"85097","DOI":"10.18632\/oncotarget.13197","volume":"7","author":"TY Fu","year":"2016","unstructured":"Fu TY, Wu CN, Sie HC, Cheng JT, Lin YS, Liou HH, Tseng YK, Shu CW, Tsai KW, Yen LM, Tseng HW, Tseng CJ, Ger LP, Liu PF (2016) Subsite-specific association of DEAD box RNA helicase DDX60 with the development and prognosis of oral squamous cell carcinoma. Oncotarget 7:85097\u201385108","journal-title":"Oncotarget"}],"container-title":["Clinical Oral Investigations"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00784-019-03129-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00784-019-03129-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00784-019-03129-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,8]],"date-time":"2020-11-08T00:39:06Z","timestamp":1604795946000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00784-019-03129-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,9]]},"references-count":44,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["3129"],"URL":"https:\/\/doi.org\/10.1007\/s00784-019-03129-y","relation":{},"ISSN":["1432-6981","1436-3771"],"issn-type":[{"value":"1432-6981","type":"print"},{"value":"1436-3771","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,9]]},"assertion":[{"value":"14 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the Institutional Review Board (IRB) at the Kaohsiung Veterans General Hospital (KVGH, IRB number: VGHKS11-CT12-13) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from the parents of all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}